Praxis Precision Medicines (PRAX) Short-term Investments (2024 - 2026)

Praxis Precision Medicines' Short-term Investments history runs 3 years deep, the most recent figure standing at $250.5 million for Q1 2026.

• In Q1 2026, Short-term Investments rose 54.25% year-over-year to $250.5 million; the TTM figure through Mar 2026 stood at $250.5 million (up 54.25% YoY), while the FY2025 annual figure was $242.0 million, up 36.57% from the prior year.
• Short-term Investments was $250.5 million for Q1 2026 at Praxis Precision Medicines, up from $242.0 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $250.5 million in Q1 2026 to a low of $55.4 million in Q1 2024.
• Historically, Short-term Investments has averaged $171.6 million across 3 years, with a median of $177.2 million in 2024.
• Biggest YoY gain for Short-term Investments was 192.99% in 2025; the steepest drop was 37.56% in 2025.
• A 3-year view of Short-term Investments shows it stood at $177.2 million in 2024, then jumped by 36.57% to $242.0 million in 2025, then increased by 3.52% to $250.5 million in 2026.
• The last three Short-term Investments figures came in at $250.5 million (Q1 2026), $242.0 million (Q4 2025), and $117.6 million (Q3 2025), per Business Quant data.